Interfocal heterogeneity challenges the clinical usefulness of molecular classification of primary prostate cancer

Abstract excerpt

Prostate cancer is a highly heterogeneous disease and typically multiple distinct cancer foci are present at primary diagnosis. Molecular classification of prostate cancer can potentially aid the precision of diagnosis and treatment. A promising genomic classifier was published by The Cancer Genome Atlas (TCGA), successfully classifying 74% of primary prostate cancers into seven groups based on one cancer sample...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer, Lipids, and Metabolism
• Share to Prostate Cancer Diagnosis and Treatment
• Share to Prostate Cancer Treatment and Research